Press release
Organon & Co. (NYSE: OGN) Investor Alert: Deadline in Lawsuit on July 22, 2025
A Deadline is coming up on July 22, 2025 in the lawsuit for certain investors in Organon & Co. (NYSE: OGN).
Investors who purchased shares of Organon & Co. (NYSE: OGN) have certain options and there are strict and short deadlines running. Deadline: July 22, 2025. NYSE: OGN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Organon & Co. (NYSE: OGN) common shares between October 31, 2024, to April 30, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between October 31, 2024, to April 30, 2025, the Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of the Company's priorities, particularly, related to capital allocation through quarterly dividends, and that the Defendants concealed the high priority of Organon's debt reduction strategy following the Company's acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend.
Those who purchased shares of Organon & Co. (NYSE: OGN) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Organon & Co. (NYSE: OGN) Investor Alert: Deadline in Lawsuit on July 22, 2025 here
News-ID: 4108927 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit filed for investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: September 5, 2025. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Long-Term Investors in shares of Ibotta, Inc. (NYSE: IBTA) should contact the Sh …
An investigation was announced for current long-term investors in shares of Ibotta, Inc. (NYSE: IBTA) concerning potential breaches of fiduciary duties by certain directors and officers of Ibotta, Inc.
Investors who are current long term investors in Ibotta, Inc. (NYSE: IBTA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Investigation announced for Long-Term Investors in shares of NET Power Inc. (NYS …
An investigation on behalf of current long-term investors in shares of NET Power Inc. (NYSE: NPWR) concerning potential breaches of fiduciary duties by certain directors and officers of NET Power Inc. was announced.
Investors who are current long term investors in NET Power Inc. (NYSE: NPWR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for…
Investors who lost money with shares in Centene Corporation (NYSE: CNC) should c …
An investor, who purchased shares of Centene Corporation (NYSE: CNC), filed a lawsuit over alleged violations of Federal Securities Laws by Centene Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Centene Corporation (NYSE: CNC) have certain options and for certain investors are short and strict deadlines running. Deadline: September 8, 2025. NYSE: CNC investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
More Releases for Organon
Contraceptives Market Detailed in New Research Report with Emerging Hormonal and …
Contraceptives Market Insights
Global contraceptive market was valued US$ 19.79 Bn in 2025 and is expected to reach US$ 47.14 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 13.20% from 2025 to 2032.
Coherent Market Insights has released a detailed analysis of the Contraceptives Market (2025-2032), focusing on the evolving U.S. healthcare landscape. The report presents critical metrics such as market size, revenue forecasts, CAGR, adoption patterns, and key…
Ganirelix Market Is Booming Worldwide 2025-2032 | Organon & Co.,Merck & Co., Inc …
According to the latest research from Coherent Market Insights, the Ganirelix Market is projected to experience significant growth between 2025 and 2032. This market intelligence report offers in-depth analysis based on thorough research, highlighting current trends, financial performance, and historical data evaluation. The company profiles within the report are derived from the current performance of the Ganirelix Market, considering key factors such as drivers, trends, and challenges, as well as…
Hypogonadism Pipeline | Clinical Trials, Key Companies -Mereo BioPharma, Merck, …
DelveInsight's, "Hypogonadism- Pipeline Insight, 2023" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hypogonadism pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download the Sample Report to learn more
@https://www.delveinsight.com/sample-request/hypogonadism-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Hypogonadism Overview
Hypogonadism occurs when your sex…
Muscle Relaxant Monitor Market | Blink Device, GE, IDMED, Organon Laboratories
The global muscle relaxant monitor market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the muscle relaxant monitor market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Testosterone Undecylate (TU) Market May See a Big Move | Major Giants Organon, B …
Latest study on the industrial growth of Testosterone Undecylate (TU) Market 2023-2030 By Stratagem Market Insights. A detailed study accumulated to offer the latest insights about acute features of the Testosterone Undecylate (TU) market. The research report studies primary and secondary research in order to analyze the data effectively. The comprehensive market study on Testosterone Undecylate (TU) focuses on both macroeconomic and microeconomic factors that support market growth. The regulatory…
Mirtazapine Tablets Market Analysis & Trends - Industry Forecast to 2027 |Novart …
LOS ANGELES, United States: The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Mirtazapine Tablets market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Mirtazapine Tablets market. The authors of the report have segmented the global Mirtazapine Tablets market as per…
